{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:57:45Z","timestamp":1769720265142,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.riam.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T14:17:05Z","timestamp":1370873825000},"page":"171-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recommendations for the management of candidemia in children in Latin America"],"prefix":"10.1016","volume":"30","author":[{"given":"Mar\u00eda E.","family":"Santolaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"de Queiroz Telles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tito","family":"Alvarado Matute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo Lopes","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannete","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris Nora","family":"Tiraboschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Alberto","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Thompson-Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Guzman-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Sifuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2013.05.010_bib0005","series-title":"Focus on fungal infections F 14","article-title":"Safety and efficacy of AmBisome in patients with fungal infections. A post marketing multicentre surveillance study in Turkey","author":"Anak","year":"2004"},{"key":"10.1016\/j.riam.2013.05.010_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0609.1996.tb00300.x","article-title":"Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukemia","volume":"56","author":"Anttila","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.riam.2013.05.010_bib0015","series-title":"MYCAMINE (micafungin sodium) for injection. Product Information","author":"Astellas","year":"2013"},{"key":"10.1016\/j.riam.2013.05.010_bib0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/AAC.50.2.632-638.2006","article-title":"Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections","volume":"50","author":"Benjamin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.surg.2006.07.029","article-title":"The vulnerabilities of age: burns in children and older adults","volume":"140","author":"Bessey","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.riam.2013.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1542\/peds.2008-2055","article-title":"Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients","volume":"123","author":"Blyth","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.riam.2013.05.010_bib0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01974613","article-title":"Pharmacokinetics of fluconazole in pediatric patients","volume":"13","author":"Brammer","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0325","unstructured":"Cancidas\u00ae (caspofungin, acetate), intravenous infusions. Product Information.Merck & Co., Inc.; 2010."},{"key":"10.1016\/j.riam.2013.05.010_bib0040","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.inf.0000220256.69385.2e","article-title":"Fungal infections in children with cancer: a prospective, multicenter surveillance study","volume":"25","author":"Castagnola","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0330","unstructured":"ClinicalTrials.gov. Study to assess the safety, pharmacokinetics, and evaluatethe response to anidulafungin when treating children with invasive candidiasis. NCT00761267 [accessed Jan 2011]. Available from: http:\/\/clinicaltrials.gov11"},{"key":"10.1016\/j.riam.2013.05.010_bib0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkm169","article-title":"Caspofungin for the treatment of less common forms of invasive candidiasis","volume":"60","author":"Cornely","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.riam.2013.05.010_bib0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0196-6553(93)90030-8","article-title":"Natural history of bloodstream infections in a burn patient population: the importance of candidemia","volume":"21","author":"Ekenna","year":"1993","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.riam.2013.05.010_bib0065","first-page":"520","article-title":"Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease","volume":"13","author":"el-Mohandes","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0070","series-title":"Mycamine Product Information","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.riam.2013.05.010_bib0075","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0080","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4081\/pr.2011.e6","article-title":"Current evidence of antifungal prophylaxis and therapy in pediatric patients","volume":"3","author":"Giacchino","year":"2011","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.riam.2013.05.010_bib0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2165\/00003495-199550040-00007","article-title":"Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients","volume":"50","author":"Goa","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.riam.2013.05.010_bib0090","series-title":"Practical clinical oncology","first-page":"426","article-title":"Cancer in children","author":"Goodman","year":"2008"},{"key":"10.1016\/j.riam.2013.05.010_bib0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1469-0691.2010.03334.x","article-title":"Update on antifungal agents for paediatric patients","volume":"16","author":"Groll","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2013.05.010_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100960000437","article-title":"Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients","volume":"20","author":"Herbrecht","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.16.1.593","article-title":"The immunogenetics of human infectious diseases","volume":"16","author":"Hill","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.riam.2013.05.010_bib0110","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00043426-199709000-00001","article-title":"Therapy-induced alterations in host defense in children receiving therapy for cancer","volume":"19","author":"Lehrnbecher","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.riam.2013.05.010_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/jhin.2002.1359","article-title":"Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors","volume":"53","author":"Levy","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.riam.2013.05.010_bib0125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF01710679","article-title":"Hepatosplenic candidiasis, a fatal disease?","volume":"20","author":"Loeliger","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.riam.2013.05.010_bib0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1086\/514580","article-title":"Risk factors for candidemia in a children's hospital","volume":"26","author":"MacDonald","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":"A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia","volume":"29","author":"Maertens","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0140","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MOP.0b013e3282f1dde9","article-title":"Invasive Candida species disease in infants and children: occurrence, risk factors, management, and innate host defense mechanisms","volume":"19","author":"Marodi","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.riam.2013.05.010_bib0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jac\/44.4.429","article-title":"The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review","volume":"44","author":"Martin","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.leukres.2004.10.003","article-title":"Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment","volume":"29","author":"Masood","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.riam.2013.05.010_bib0160","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1378\/chest.124.6.2244","article-title":"Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients","volume":"124","author":"Michalopoulos","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.riam.2013.05.010_bib0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.PCC.0000144712.29127.81","article-title":"Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study","volume":"5","author":"Mondal","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.riam.2013.05.010_bib0170","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"issue":"3\u20134","key":"10.1016\/j.riam.2013.05.010_bib0175","first-page":"291","article-title":"Pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus infection","volume":"48","author":"Nahata","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.riam.2013.05.010_bib0180","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/AAC.43.6.1417","article-title":"Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion","volume":"43","author":"Nath","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0190","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.riam.2013.05.007","article-title":"Recommendations for the management of candidemia in adults in Latin America","volume":"30","author":"Nucci","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2013.05.010_bib0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","article-title":"Invasive candidiasis","volume":"20","author":"Pappas","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.riam.2013.05.010_bib0205","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.05.010_bib0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/516658","article-title":"Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place","volume":"28","author":"Pasqualotto","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.riam.2013.05.010_bib0215","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood.V90.10.3858","article-title":"Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia","volume":"90","author":"Pestalozzi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.riam.2013.05.010_bib0220","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.1997.2473063.x","article-title":"A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients","volume":"98","author":"Prentice","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.riam.2013.05.010_bib0225","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2141.1999.01592.x","article-title":"Hepatosplenic candidiasis in patients with acute leukaemia","volume":"106","author":"Sallah","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.riam.2013.05.010_bib0235","first-page":"157","article-title":"Recommendations for the management of candidemia in neonates in Latin America","volume":"30","author":"Santolaya","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2013.05.010_bib0240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.1875-9114.1995.tb04331.x","article-title":"Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases","volume":"15","author":"Seay","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.riam.2013.05.010_bib0245","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0250","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2214\/ajr.169.5.9353448","article-title":"Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging","volume":"169","author":"Semelka","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.riam.2013.05.010_bib0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jmri.1880020315","article-title":"Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging","volume":"2","author":"Semelka","year":"1992","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.riam.2013.05.010_bib0260","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004630-199507000-00011","article-title":"Candidemia in the pediatric patient with burns","volume":"16","author":"Sheridan","year":"1995","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.riam.2013.05.010_bib0265","series-title":"The MASCC Textbook of Cancer Supportive Care and Survivorship","article-title":"Supportive care in paediatric oncology","author":"van de Wetering","year":"2010"},{"key":"10.1016\/j.riam.2013.05.010_bib0270","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/INF.0b013e3181e7db7f","article-title":"Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation","volume":"29","author":"Villarroel","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0275","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0280","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2013.05.010_bib0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2013.05.010_bib0290","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0295","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/1097-0142(19951201)76:11<2357::AID-CNCR2820761126>3.0.CO;2-H","article-title":"Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia","volume":"76","author":"Walsh","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.riam.2013.05.010_bib0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0885066609358952","article-title":"Prevention of central venous catheter bloodstream infections","volume":"25","author":"Walz","year":"2010","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.riam.2013.05.010_bib0305","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1185\/03007995.2010.487796","article-title":"Candidemia in children","volume":"26","author":"Zaoutis","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.riam.2013.05.010_bib0310","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.inf.0000128781.77600.6f","article-title":"Risk factors for disseminated candidiasis in children with candidemia","volume":"23","author":"Zaoutis","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.riam.2013.05.010_bib0315","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.2008-1158","article-title":"A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.riam.2013.05.010_bib0320","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/655698","article-title":"Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention","volume":"51","author":"Zaoutis","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140613000557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140613000557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:06:06Z","timestamp":1761105966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140613000557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1130140613000557"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2013.05.010","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the management of candidemia in children in Latin America","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Revista Iberoamericana de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}